Article in Nuclear medicine and biology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
2 citing papers in PubMed, 5 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
5 authors at 2 institutions in 1 country.
Jinbin XuDepartment of Radiology, School of Medicine, Washington University in Saint Louis, Saint Louis, MO 63110, USA. Electronic address: jinbinxu@wustl.edu.
Huaping ChenDepartment of Radiology, School of Medicine, Washington University in Saint Louis, Saint Louis, MO 63110, USA.
Buck E RogersRadiation Oncology, School of Medicine, Washington University in Saint Louis, Saint Louis, MO 63110, USA.
John A KatzenellenbogenDepartment of Chemistry and Cancer Center at Illinois, University of Illinois at Urbana-Champaign, Urbana, IL 61801, USA.
Dong ZhouDepartment of Radiology, School of Medicine, Washington University in Saint Louis, Saint Louis, MO 63110, USA. Electronic address: zhoud@wustl.edu.
University of Illinois Urbana-Champaign · USWashington University in St. Louis · US
Funding
RATIONAL DESIGN OF BREAST TUMOR IMAGING AGENTSR01CA025836 · NCI · UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN · PI KATZENELLENBOGEN, JOHN A. · 1985 to 2017
$4.2M
Dissect the mechanisms of selective regional vulnerability in Lewy Body Dementias via comparative snRNA-seq analysisR01NS123571 · NINDS · WASHINGTON UNIVERSITY · PI XU, JINBIN, ZHAO, GUOYAN · 2021 to 2025
$3.6M
Imaging and Targeted Auger Radiotherapy of High-Grade GliomaR01EB029752 · NIBIB · WASHINGTON UNIVERSITY · PI GARBOW, JOEL RICHARD, ROGERS, BUCK E. · 2020 to 2023
$3.1M
POSTMORTEM VALIDATION OF BIOMARKERS FOR IMAGING PARKINSON DISEASER01NS092865 · NINDS · WASHINGTON UNIVERSITY · PI XU, JINBIN · 2016 to 2020
$1.7M
Optimization of imaging mass cytometry, a single-cell spatial proteomics technology, for the study of Alzheimer diseaseR21AG077643 · NIA · WASHINGTON UNIVERSITY · PI XU, JINBIN, ZHAO, GUOYAN · 2022 to 2022
$433k
Small Molecule GPCR Ligands for Oncologic ImagingR21EB028302 · NIBIB · WASHINGTON UNIVERSITY · PI ROGERS, BUCK E., XU, JINBIN · 2020 to 2021
$433k
Define molecular events driving selective neuronal death in multiple neurodegenerative diseases by snRNA-seqR03AG070474 · NIA · WASHINGTON UNIVERSITY · PI XU, JINBIN, ZHAO, GUOYAN · 2021 to 2022
$315k
DOPAMINE D1, D2, AND D3 RECEPTORS AS BIOMARKERS FOR IMAGING NIGROSTRIATAL NEURONSR03NS090214 · NINDS · WASHINGTON UNIVERSITY · PI XU, JINBIN · 2014 to 2015
introductionSolid-phase synthesis and conjugation reactions of acids and amines using coupling reagents are common in organic synthesis, but rare in
methodsFluoro-, bromo- and iodo-benzoic derivatives of olaparib were synthesized, and their PARP-1 affinities were measured using a recently developed cell culture-based competitive assay. To produce [
resultsThe best derivatives of olaparib were identified as compound 4, 7 and 8. [
conclusionsThis method is simple and efficient, having great potential for the synthesis of radiopharmaceuticals starting from [
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Solid phase radiosynthesis of an olaparib derivative using 4-[ · full record | OpenQuestion